Feasibility of a Minimally Invasive Diagnostic Algorithm in Suspected Crohn's Disease

NCT06882993 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 165

Last updated 2025-03-19

No results posted yet for this study

Summary

The goal of this clinical trial is to learn whether a camera pill examination of the whole bowel can be used to diagnose Crohn's disease instead of colonoscopy and a small bowel examination (either MRI or camera pill) in patients aged 18-40 years suspected of having Crohn's disease.

The main question it aims to answer is:

How many patients examined with a camera pill examination of the whole bowel will have a complete examination of the whole bowel and have a diagnosis made without need for any more examinations?

Researchers will compare with patients examined with colonoscopy and a small bowel examination.

Participants will:

* Be examined with either a camera pill examination of the whole bowel, or a colonoscopy and a small bowel examination
* Have their electronic medical records checked to see if a diagnosis has been made
* Have an interview every three months if diagnosed with an inflammatory bowel disease or after a year if no disease was found

Conditions

Interventions

DIAGNOSTIC_TEST

Panenteric capsule endoscopy

Panenteric capsule endoscopy

DIAGNOSTIC_TEST

Ileocolonoscopy

Endoscopic examination of the colon and terminal ileum after bowel preparation.

DIAGNOSTIC_TEST

MRI enterography

MRI of the small bowel

DIAGNOSTIC_TEST

Small bowel capsule endoscopy

Capsule endoscopy of the small bowel

Sponsors & Collaborators

  • Odense University Hospital

    collaborator OTHER
  • Svendborg Hospital

    collaborator OTHER
  • Skane University Hospital

    collaborator OTHER
  • Vejle Hospital

    collaborator OTHER
  • Esbjerg Hospital - University Hospital of Southern Denmark

    lead OTHER

Principal Investigators

  • Frederik D Thrane, MD · Esbjerg Hospital - University Hospital of Southern Denmark

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-02-26
Primary Completion
2027-08-31
Completion
2028-08-31

Countries

  • Denmark
  • Sweden

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06882993 on ClinicalTrials.gov